CClinicalTrials.gg
Status unknownNCT04569955Updated Sep 30, 2020

Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt

An observational study in Breast Cancer and Clinical Trials, sponsored by Ain Shams University. Status unknown at 1 site in Egypt. Open to female participants aged Up to 80 Years. Per ClinicalTrials.gov, last updated 2020-09-30.

Sponsored by Ain Shams University · Observational

The sponsor has not verified this record recently (last verified Sep 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
300
Ages
Up to 80 Years
Sex
Female
01

Study summary

  • Clinical trials are essential to translate new therapy concepts or rather any intervention into the medical routine. Beside the well designed trial protocol, the success of clinical trials depends on patient recruitment and participation.
  • This study aims to get a current picture of the patients' knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries.
02

Conditions studied

  • Breast Cancer
  • Clinical Trials

Browse trials for

03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 300 is above the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

-Egyptian female Breast cancer patients

Inclusion criteria

  • Female breast cancer patients

Exclusion criteria

Exclusion Criteria:

  • Patients who refuse participation
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
300 participants (estimated)
Patient registry
No

Interventions

  • BehavioralKnowledge and perception of clinical trial participation

    This study aims to get a current picture of the patients' knowledge and perception of clinical trial participation in Breast cancer female patients in Egypt, as an example to Low/Middle income countries

06

What researchers measure

Primary outcomes

  1. The percentage of breast cancer patients who accept to participate in clinical trials

    Time frame: 1 year

Secondary outcomes

  1. The barriers for participation in clinical trials

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • Ain shams university, faculty of medicine
    Cairo, Select 1667, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 30, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04569955
Lead sponsor
Ain Shams University
Responsible party
Hagar Elghazawy (Lecturer of clinical oncology, Ain Shams University) — Principal investigator
First posted
Sep 30, 2020
Start date
Jul 20, 2020
Primary completion
Dec 2020 (estimated)
Completion
Dec 2020 (estimated)
Last update
Sep 30, 2020

Study contacts

Hagar Elghazawy, MD
Contact
dr.hagar.elghazawy@med.asu.edu.eg
01006232406
Hagar Elghazawy
principal investigator · Ain shams university, faculty of medicine

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion